{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:20:17Z","timestamp":1773487217544,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00228-023-03590-5","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T15:05:01Z","timestamp":1702998301000},"page":"283-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6341-6001","authenticated-orcid":false,"given":"Jean-Louis","family":"Montastruc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7469-2407","authenticated-orcid":false,"given":"Alessandra","family":"Bura-Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"3590_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.phrs.2016.08.017","volume":"118","author":"S Laporte","year":"2017","unstructured":"Laporte S, Chapelle C, Caillet P, Beyens MN, Bellet F, Delavenne X, Mismetti P, Bertoletti L (2017) Bleeding risk underrselective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies. Pharmacol Res 118:19\u201332","journal-title":"Pharmacol Res"},{"key":"3590_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/JCP.0000000000001684","volume":"43","author":"C Monteiro Machado","year":"2023","unstructured":"Monteiro Machado C, Alves M, Caldeira D (2023) Impact of selective serotonin-reuptake inhibitors in hemorrhagic risk in anticoagulated patients taking non-vitamin K antagonist anticoagulants; a systematic review and meta-analysis. J Clin Psychopharmacol 43:267\u2013267","journal-title":"J Clin Psychopharmacol"},{"key":"3590_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1055\/a-1932-8976","volume":"123","author":"AA Rahman","year":"2023","unstructured":"Rahman AA, He N, Rej S, Platt RW, Renoux C (2023) Concomitant use of selective serotonin reuptake inhibitors and oral anticoagulants and risk of major bleeding: a systematic review and meta-analysis. Thromb Haemost 123:54\u201363","journal-title":"Thromb Haemost"},{"key":"3590_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.therap.2018.08.001","volume":"74","author":"JL Montastruc","year":"2019","unstructured":"Montastruc JL, Benevent J, Montastruc F, Bagheri H, Despas F, Lapeyre-Mestre M, Sommet A (2019) What is pharmacoepidemiology? Definition, methods, interest and clinical applications. Therapie 74:169\u2013174","journal-title":"Therapie"},{"key":"3590_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00228-023-03480-w","volume":"79","author":"JL Montastruc","year":"2023","unstructured":"Montastruc JL, Montastruc F, Bura-Riviere A (2023) Tramadol and the risk of bleeding complications in patients on oral anticoagulants: a pharmacovigilance study. Eur J Clin Pharmacol 79:701\u2013702","journal-title":"Eur J Clin Pharmacol"},{"key":"3590_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","volume":"22","author":"J-L Montastruc","year":"2011","unstructured":"Montastruc J-L, Sommet A, Bagheri H, Lapeyre-Mestre M (2011) Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol 22:905\u2013908","journal-title":"Br J Clin Pharmacol"},{"key":"3590_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.therap.2019.01.006","volume":"74","author":"J-L Faillie","year":"2019","unstructured":"Faillie J-L (2019) Case non-case studies: Principles, methods, bias and interpretation. Therapie 74:225\u2013232","journal-title":"Therapie"},{"key":"3590_CR8","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"R Edwards","year":"2000","unstructured":"Edwards R, Aronson J (2000) Adverse drug reactions: Definitions, diagnosis, and management. Lancet 356:1255\u20131259","journal-title":"Lancet"},{"key":"3590_CR9","unstructured":"Nichols CD, Amara SG, Sibley DR (2023) 5-Hydroxytryptamine (serotonin) and dopamine. In: Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics, 14th ed. New York McGraw-Hill, pp 285\u2013304"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03590-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-023-03590-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03590-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T10:03:16Z","timestamp":1707472996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-023-03590-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["3590"],"URL":"https:\/\/doi.org\/10.1007\/s00228-023-03590-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"20 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}